School of Medicine
Showing 1-50 of 121 Results
-
Michael Salerno
Professor of Medicine (Cardiovascular) and of Radiology (Cardiovascular Imaging)
BioDr. Salerno completed his BS in Biological Engineering at Cornell University, and his MD and PhD in Biomedical Engineering at the University of Virginia as part of the Medical Scientist Training Program. He then completed the American Board of Internal Medicine Research Pathway with an Internal Medicine residency at Stanford University, and his general cardiology fellowship at Duke University Medical Center. During his time at Duke he completed a dedicated year in cardiovascular MRI at the Duke Cardiovascular MR Imaging Center. He returned to UVA in 2008 to complete a 2-year advanced cardiovascular imaging fellowship where he trained in CMR and cardiovascular CTA. He achieved COCATS Level III training in all cardiovascular imaging modalities (Echo, Nuclear, CMR, CCT), and is board certified in Echocardiography and Nuclear Cardiology. He served as faculty at UVA in Cardiology, Radiology, and Biomedical Engineering from 2010-2021 where he was the Director of Cardiac MRI and the Medical Director of Echocardiography, before returning to Stanford.
His research involves the development and evaluation of novel MRI pulse sequences and techniques to improve the clinical utility of CMR imaging. The current focus of the research is on quantitative myocardial perfusion imaging, quantitative imaging of myocardial fibrosis, rapid free-breathing and self-gated imaging, and deep learning for image reconstruction and post-processing. His laboratory includes undergraduate and graduate engineering students as well as clinical cardiovascular imaging fellows to bring new advances into clinical practice. Dr. Salerno has been in the field of MRI for 25 years and holds multiple patents related to the development and application of novel pulse sequences for MRI. He has received numerous research awards, and has published extensively in the areas of MRI, cardiovascular MRI and multi-modality cardiovascular imaging. His research has been supported by the AHA and the National Institutes of health. He is a deputy editor for JACC Cardiovascular Imaging.
Outside of work, Dr. Salerno enjoys sailing, rock climbing, skiing, running, biking, hiking, and spending time with his wife Cherie, and his two boys Christopher and Joseph. -
Karim Sallam, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioKarim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.
-
Arghavan Salles
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Salles is a minimally invasive and bariatric surgeon. She completed medical school and residency in general surgery at Stanford prior to completing her fellowship in minimally invasive surgery at Washington University in St. Louis. She stayed on faculty at Washington University for three years prior to moving back to Stanford. Dr. Salles obtained a PhD in education from Stanford University during her residency training, and her research focuses on gender equity, implicit bias, diversity, inclusion, and physician well-being. Dr. Salles became a COVID Frontliner in 2020 and served in ICUs in New York and Arizona. She has written and spoken about these experiences in popular press outlets such as Newsweek, NBC, and CBS. She is a sought-after speaker and has given over 80 national and international invited talks related to gender equity, physician well-being, and weight bias.
-
Alexander Tarlochan Singh Sandhu
Assistant Professor of Medicine (Cardiovascular Medicine)
BioAlex Sandhu, MD, MS is a cardiologist with a special interest in the care of patients with advanced heart failure. He graduated from the seven-year combined BA-MD program at Northwestern Feinberg School of Medicine. He completed an internal medicine residency at Stanford University, spending 16 weeks at Makerere Hospital in Uganda as part of the Global Health track. He subsequently obtained completed a Masters in Health Services Research at Stanford while acting as a fellow in health services research at the Palo Alto VA and Stanford's Center for Health Policy/Primary Care and Outcomes Research. Next, he completed fellowships in cardiology and advanced heart failure and transplant at Stanford before joining the faculty.
Alex is now an active clinician and heart failure researcher who focuses on health economics, the implementation of high-value care strategies, and comparative effectiveness. He is involved in three clinical trials at this time: K-23 funded PRO-HF (patient centered quality of life assessments), DOT-HF (mobile device based implementation trial), and a CAC notification pilot trial (patient centered coronary artery calcification notification).
In his free time, he enjoys entertaining and being entertained by his ebullient sons, Kyle and Tyler. -
Ryan Sandoval, M.D.
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sandoval is a board-certified cardiologist and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. He completed his residency at the University of Texas at Austin, where he continued on as chief resident before going on to complete his fellowship in cardiovascular disease at the Medical University of South Carolina. Prior to his residency, he completed a research fellowship at Massachusetts General Hospital (MGH).
His clinical interests include preventive cardiology and management of heart failure. He is particularly focused on treating patients with the complex clinical syndrome of heart failure with preserved ejection fraction (HFpEF).
His interest in preventive cardiology grew through his participation in clinics for the uninsured and underinsured during his training. These experiences fostered his passion for understanding and addressing health care disparities. He is deeply committed to providing exceptional patient care with a personalized approach to treatment and improving the lives of his patients.
He is a member of the American College of Cardiology. -
Rebecca Sands
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Sands currently serves as the Clinical Section Chief of Palliative Care at Stanford University. She graduated from Franklin & Marshall College in 2001 with a BA in Chemistry. She then attended Midwestern University, Chicago College of Osteopathic Medicine from 2002-2006. She completed a residency and chief residency in Internal Medicine at Cambridge Health Alliance in Cambridge, MA and went on to complete her Hospice and Palliative Medicine (HPM) fellowship at the Harvard combined program at Massachusetts General Hospital/Dana Farber Cancer Institute in 2011. She spent 8 years at the University of Pittsburgh where she served as core teaching faculty and the HPM Fellowship Program Director. Her clinical work has focused on the intersection of oncology and palliative care. Her primary interests are in mentorship and the advancement of palliative care within the structure of academic medicine including ambulatory practice. She has a particular focus on resiliency skill development for trainees, staff, and faculty as well a commitment to the innovation of ways to create meaning in our everyday lives as health care professionals.
-
Everton Jose Santana
Visiting Instructor/Lecturer, Medicine - Cardiovascular Medicine
BioEverton is currently a Visiting Instructor at Stanford University, Division of Cardiovascular Medicine in the School of Medicine.
He has received his BSc degree in Electrical Engineering (2019) and MSc degree in Computer Science (2021) by the State University of Londrina (UEL), Brazil. From 2015 to 2016, he was an exchange student at Hanze University of Applied Sciences, the Netherlands, where he followed minors in Biomedical and Sensor System Engineering.
He has worked with several Research and Development projects, englobing Machine Learning and Instrumentation Engineering applied to many domains.
He has also worked as a Professor at the Pontifical Catholic University of Paraná in the Cyber-Physical Systems theme.
His current research interest is in Data Science applied to Biomedical Signals. -
Anuja Anand Sathe
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.
-
Amelia Sattler, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCurrently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.
Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health. -
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Lidia Schapira
Professor of Medicine (Oncology)
BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and serves as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology.
-
Erika Schillinger
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).
-
Ingela Schnittger, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.
-
Gary Schoolnik
Professor of Medicine (Infectious Diseases), Emeritus
Current Research and Scholarly InterestsStructure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses
-
John S. Schroeder, MD
Professor (Clinical) of Medicine (Cardiovascular)
Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
(a) Calcium Channel Blockers
(b) Agents for Heart Failure
(c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers
2. Cardiac Transplantation/Congestive Heart Failure
3. Coronary Artery Spasm -
Joseph Schroers-Martin
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsMedical heme/onc focused on molecular cancer diagnostics and novel biomarkers.
-
Kevin Schulman
Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business
BioDr. Schulman serves as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He is the Director of Stanford's master degree program, the Master of Science in Clinical Informatics Management.
Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 500 publications, Kevin Schulman has had a broad impact on health policy (h-index = 80). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Editor in Chief of Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.
Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master’s of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.
He is a co-founder of Bivarus (exit January, 2018), co-founder and Managing Member of Faculty Connection, LLC., and is a Board Member of Grid Therapeutics.
He is an elected member of ASCI and AAP.
He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program. -
Jake Scott
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.
Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.
One of Dr. Scott’s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
He is the medical director of the Antimicrobial Stewardship Program at Stanford Health Care – ValleyCare in Pleasanton and is a member of the Infection Control Committee and the Stanford Vaccine Clinical Advisory Committee.
In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his wife and two young children. -
Katharine Sears Edwards
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.
Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).
Assessment and training in evidence-based psychological therapies. -
Rebecca Seekamp, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsInterested in complementary/alternative medicine, international health, international adoption medicine and providing full spectrum health care.
-
Niraj Sehgal
Clinical Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement & Patient Safety, Teamwork & Communication, Leadership
Development, Organizational Culture & Change -
Deborah Sellmeyer
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Atulkumar T. Shah, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care’s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.
Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.
Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.
After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a “one-stop” resource for truly comprehensive care.
Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.
Among Dr. Shah’s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.
Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.
As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India. -
Mamta Madhav Shah, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
She provides care for patients with a variety of kidney-related conditions, with a special interest in management of kidney stones and related conditions. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given several talks on kidney stones to trainees and peers. Dr. Shah previously served as medical director of one of the dialysis clinics at University of Connecticut Health Center and helped run the plasmapheresis treatments.
Some of Dr. Shah’s recent research is focused on efforts to prevent filter failure when performing membrane-based therapeutic plasma exchange—a blood purification treatment for removing large molecular weight substances from plasma.
Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.
Dr. Shah is a member of the American Society of Nephrology. She has a keen interest in education of trainees including medical students, residents and fellows; and served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center.
She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and daughter. -
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsWe analyze multiple types of health data (EHR, Claims, Wearables, Weblogs, and Patient blogs), to answer clinical questions, generate insights, and build predictive models for the learning health system.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NASDAQ:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
BioDr. Sumit Shah specializes in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. He also serves as an investigator on numerous clinical trials, with a focus on novel immunotherapy agents. His academic interests also include digital health technologies and novel healthcare delivery services, both in the domestic and international setting. Dr. Shah graduated with distinction in biomedical engineering from Duke University, received his medical doctorate from Stanford University, and Masters in Public Health from Harvard University. He completed his internal medicine residency at the University of California, San Francisco (UCSF) where he stayed on faculty for one year before returning to Stanford for his fellowship training in medical oncology, where he now serves on the faculty.
-
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Instructor, Medicine - Oncology
BioWith a primary focus on high-dimensional data, I have significant expertise in developing machine learning tools. Much of my work involves constructing Bayesian models, which effectively convert 'prior knowledge', either inherent in the dataset or obtained from external sources, into mathematical terms—more specifically, prior probabilities.
My recent research efforts have centered on the analysis of genetic and epigenetic signals within cell-free DNA assays. This interest in epigenetics led to the development of a pioneering technique known as EPIC-seq, which has broadened our understanding of this complex field.
It's notable that traditional computational methods in cancer genomics often fall short when confronted with an exceedingly low signal-to-noise ratio—a common scenario in cfDNA analyses. As such, there's an emerging need to devise innovative, robust methods capable of overcoming this limitation—a research area that I'm deeply committed to and actively engaged in.
